2019
DOI: 10.1080/14728222.2019.1571043
|View full text |Cite
|
Sign up to set email alerts
|

The MAP kinase-interacting kinases (MNKs) as targets in oncology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
29
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
4
1
1

Relationship

1
5

Authors

Journals

citations
Cited by 33 publications
(30 citation statements)
references
References 104 publications
1
29
0
Order By: Relevance
“…Most other studies, which typically focus on the effect of MNK inhibition on levels of specific proteins on one or few candidates, are largely without any mechanistic rationale. Also, as they often use small molecule inhibitors of the MNKs which are now known to exert substantial offtarget effects (13), they too are difficult to contextualise in relation to our new data.…”
Section: Capclip Indicates That Phosphorylation Of Eif4e Generally Dementioning
confidence: 99%
See 3 more Smart Citations
“…Most other studies, which typically focus on the effect of MNK inhibition on levels of specific proteins on one or few candidates, are largely without any mechanistic rationale. Also, as they often use small molecule inhibitors of the MNKs which are now known to exert substantial offtarget effects (13), they too are difficult to contextualise in relation to our new data.…”
Section: Capclip Indicates That Phosphorylation Of Eif4e Generally Dementioning
confidence: 99%
“…The two mammalian MNKs, MNK1 and MNK2 (MKNK1 and MKNK2 are the human genes) each give rise to two splice forms, which in turn produce differing protein C-termini that affect the subcellular distribution of the corresponding MNK proteins and their association with upstream MAP kinases. Both mouse and human MNK2 are constitutively active and phosphorylate eIF4E under basal conditions, while MNK1 is strongly activated by upstream MAPK signalling and therefore plays a much greater role in inducible phosphorylation of eIF4E (reviewed in (13)). eIF4E is the only known substrate of the MNKs in vivo (13).…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…Therefore, development of cancer cell protein synthesis inhibitory strategies is arousing growing interest in cancer research (Bhat et al, ). Such strategies include inhibition of specific targets in the translation machinery (Itoua Maïga et al, ) as well as inhibitors of upstream signaling pathways involved at different stages of cancer development (Bhat et al, ; Xie, Merrett, Jensen, & Proud, ).…”
Section: Introductionmentioning
confidence: 99%